Cargando...

Interaction Potential of the Multitargeted Receptor Tyrosine Kinase Inhibitor Dovitinib with Drug Transporters and Drug Metabolising Enzymes Assessed in Vitro

Dovitinib (TKI-258) is under development for the treatment of diverse cancer entities. No published information on its pharmacokinetic drug interaction potential is available. Thus, we assessed its interaction with important drug metabolising enzymes and drug transporters and its efficacy in multidr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Pharmaceutics
Main Authors: Weiss, Johanna, Theile, Dirk, Dvorak, Zdenek, Haefeli, Walter Emil
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2014
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4279137/
https://ncbi.nlm.nih.gov/pubmed/25521244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics6040632
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!